Obesity and inflammation in children

Sarah Jane Schwarzenberg1, Alan R Sinaiko

  • 1Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA. schwa005@umn.edu

Insights

Systemic inflammation is linked to obesity in all age groups. Addressing this inflammation through weight loss, exercise, or medication may help reduce related health issues like insulin resistance.

Area of Science:

  • Endocrinology
  • Immunology
  • Metabolic Syndrome

Background:

  • Obesity is associated with systemic inflammation in both children and adults.
  • This inflammation is implicated in the development of insulin resistance and atherosclerosis.
  • White adipose tissue, often viewed as inert, is a metabolically active organ producing inflammatory cytokines.

Purpose of the Study:

  • To explore the role of inflammation in obesity.
  • To understand how inflammation contributes to obesity-related comorbidities.
  • To investigate potential interventions for obesity-associated inflammation.

Main Methods:

  • Review of existing literature on obesity, inflammation, and metabolic dysfunction.
  • Analysis of the role of white adipose tissue as an endocrine organ.
  • Examination of factors influencing obesity-associated inflammation.

Main Results:

  • Systemic inflammation is a key feature of obesity.
  • Inflammation from adipose tissue contributes to insulin resistance and atherosclerosis.
  • Weight loss, exercise, and potentially medications can reduce obesity-associated inflammation.

Conclusions:

  • Inflammation in the context of excessive adipose tissue is crucial for understanding obesity.
  • Modifying obesity-associated inflammation may reduce comorbidities independently of weight loss.
  • Targeting inflammation offers a therapeutic strategy for managing obesity and its complications.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammation01:38

Inflammation

Overview
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...